Neurodegenerative diseases (NDs) such as Alzheimer disease (AD), Parkinson disease
(PD), and Huntington disease (HD) represent a major socio-economic challenge in view of …

Abstract The World Health Organization estimates that by the year 2040, neurodegenerative
diseases will be the second leading cause of death in developed countries, overtaking …

Neurodegenerative disorders (NDDs) are characterized by progressive loss of selectively
vulnerable neuronal populations and myelin sheath, leading to behavioral and cognitive …

Parkinson's disease (PD) is a neurodegenerative disease second only to Alzheimer's
disease in terms of prevalence. Previous studies have indicated that the occurrence and …

The escalating prevalence of neurodegenerative diseases (NDDs) within an aging global
population presents a pressing challenge. The multifaceted pathophysiological mechanisms …

Spinocerebellar ataxias (SCAs) are a large and diverse group of autosomal-dominant
neurodegenerative diseases. No drugs have been approved for these relentlessly …

Hyperbaric Oxygen (HBO2) has been proposed as a pre-conditioning method to enhance
exercise performance. Most prior studies testing this effect have been limited by inadequate …

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the
gradual loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) …

The degeneration of dopamine (DA) neurons is known to be associated with defects in
mitochondrial biogenesis caused by aging, environmental factors, or mutations in genes …

Abstract Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that
causes significant neurodegeneration. Methylmercury (MeHg+) is a neurotoxin that induces …